| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 133, Issue 1 227-233, Copyright © 1984 by American Association of Immunologists
ARTICLES |
S Izui, VE Kelley, K Masuda, H Yoshida, JB Roths and ED Murphy
The effect of the autosomal mutant gene lpr (lymphoproliferation) on the development of various autoantibodies and immune complex (IC) glomerulonephritis was investigated in four genetically distinct strains of mice: MRL/ MpJ , C3H/HeJ, C57BL/6J, and AKR/J. The presence of the lpr gene not only enhanced the production of autoantibodies in the autoimmune MRL/ MpJ strain, but also induced the formation of various kinds of autoantibodies in the three other strains of mice without any apparent predisposition to autoimmune disease. Autoantibodies induced by the lpr gene included anti-double-stranded DNA, anti-single-stranded DNA, anti-IgG, anti-thymocyte, and anti-serum glycoprotein gp70. This indicates that the action of the lpr gene on the development of autoantibody response does not require the particular abnormalities of the MRL genome. The differences in amounts and types of autoantibodies among the lpr strains reflect the difference in the background genome of each strain, suggesting the participation of other genes or factors determining the quantity and/or specificity of autoantibodies. In addition to the development of autoantibodies, the three nonautoimmune strains of mice produced high levels of unidentified IC in the presence of the lpr gene, detectable by the C1q and the conglutinin binding tests. Their glomerular lesions, however, were relatively limited when compared with MRL/ MpJ -lpr/lpr mice, which developed severe glomerulonephritis early in their life. These results suggest that the lpr gene is able to induce the formation of various autoantibodies and IC at significant concentrations in nonautoimmune mice, but for the full manifestation of systemic lupus erythematosus there may be a requirement for supplemental genetic abnormalities or factors.
This article has been cited by other articles:
|
|
 |
|
  E. Cretney, A. P. Uldrich, F. W. McNab, D. I. Godfrey, and M. J. Smyth No requirement for TRAIL in intrathymic negative selection Int. Immunol., February 1, 2008; 20(2): 267 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Neumann, T. Tschernig, D. Popa, A. Schmiedl, G. P. de Lema, K. Resch, and M. U. Martin Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms Int. Immunol., December 1, 2006; 18(12): 1779 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nijnik, H. Ferry, G. Lewis, E. Rapsomaniki, J. C. H. Leung, A. Daser, T. Lambe, C. C. Goodnow, and R. J. Cornall Spontaneous B cell hyperactivity in autoimmune-prone MRL mice Int. Immunol., July 1, 2006; 18(7): 1127 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Jimenez-Caliani, S. Jimenez-Jorge, P. Molinero, J. M. Fernandez-Santos, I. Martin-Lacave, A. Rubio, J. M. Guerrero, and C. Osuna Sex-Dependent Effect of Melatonin on Systemic Erythematosus Lupus Developed in Mrl/Mpj-Faslpr Mice: It Ameliorates the Disease Course in Females, whereas It Exacerbates It in Males Endocrinology, April 1, 2006; 147(4): 1717 - 1724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Komori, H. Furukawa, S. Mori, M. R. Ito, M. Terada, M.-C. Zhang, N. Ishii, N. Sakuma, M. Nose, and M. Ono A Signal Adaptor SLAM-Associated Protein Regulates Spontaneous Autoimmunity and Fas-Dependent Lymphoproliferation in MRL-Faslpr Lupus Mice J. Immunol., January 1, 2006; 176(1): 395 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Christensen, M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus J. Exp. Med., July 18, 2005; 202(2): 321 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Fleming, M. Monestier, and G. C. Tsokos Accelerated Ischemia/Reperfusion-Induced Injury in Autoimmunity-Prone Mice J. Immunol., September 15, 2004; 173(6): 4230 - 4235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yajima, K. Sakamaki, and S. Yonehara Age-related thymic involution is mediated by Fas on thymic epithelial cells Int. Immunol., July 1, 2004; 16(7): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Haugbro, J C Nossent, T Winkler, Y Figenschau, and O P Rekvig Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity Ann Rheum Dis, April 1, 2004; 63(4): 386 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sekine, H. Watanabe, and G. S. Gilkeson Enrichment of Anti-Glomerular Antigen Antibody-Producing Cells in the Kidneys of MRL/MpJ-Faslpr Mice J. Immunol., March 15, 2004; 172(6): 3913 - 3921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Kong, L. Morel, B. P. Croker, and J. Craft The Centromeric Region of Chromosome 7 from MRL Mice (Lmb3) Is an Epistatic Modifier of Fas for Autoimmune Disease Expression J. Immunol., March 1, 2004; 172(5): 2785 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Poe, K. M. Haas, J. Uchida, Y. Lee, M. Fujimoto, and T. F. Tedder Severely Impaired B Lymphocyte Proliferation, Survival, and Induction of the c-Myc:Cullin 1 Ubiquitin Ligase Pathway Resulting from CD22 Deficiency on the C57BL/6 Genetic Background J. Immunol., February 15, 2004; 172(4): 2100 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Karray, C. Kress, S. Cuvellier, C. Hue-Beauvais, D. Damotte, C. Babinet, and M. Levi-Strauss Complete Loss of Fas Ligand Gene Causes Massive Lymphoproliferation and Early Death, Indicating a Residual Activity of gld Allele J. Immunol., February 15, 2004; 172(4): 2118 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. A. Mongini, A. E. Jackson, S. Tolani, R. J. Fattah, and J. K. Inman Role of Complement-Binding CD21/CD19/CD81 in Enhancing Human B Cell Protection from Fas-Mediated Apoptosis J. Immunol., November 15, 2003; 171(10): 5244 - 5254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Do, A. Q. Rafi-Janajreh, R. J. Mckallip, P. S. Nagarkatti, and M. Nagarkatti Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease Int. Immunol., November 1, 2003; 15(11): 1327 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Drappa, L. A. Kamen, E. Chan, M. Georgiev, D. Ashany, F. Marti, and P. D. King Impaired T Cell Death and Lupus-like Autoimmunity in T Cell-specific Adapter Protein-deficient Mice J. Exp. Med., September 2, 2003; 198(5): 809 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Cohen Autoimmunity and Lymphoproliferation: Two Genes are Worse than One Mol. Interv., November 1, 2002; 2(7): 427 - 430. [Abstract] [Full Text]
|
|
|
|
|
|
X. Shi, C. Xie, D. Kreska, J. A. Richardson, and C. Mohan Genetic Dissection of SLE: SLE1 and FAS Impact Alternate Pathways Leading to Lymphoproliferative Autoimmunity J. Exp. Med., August 5, 2002; 196(3): 281 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, N. Jiang, C. Deppong, J. Singh, G. Dolecki, D. Mao, L. Morel, and H. D. Molina A Role for the Cr2 Gene in Modifying Autoantibody Production in Systemic Lupus Erythematosus J. Immunol., August 1, 2002; 169(3): 1587 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Mitchell, M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression J. Immunol., March 1, 2002; 168(5): 2538 - 2543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Fields, C. L. Sokol, A. Eaton-Bassiri, S.-j. Seo, M. P. Madaio, and J. Erikson Fas/Fas Ligand Deficiency Results in Altered Localization of Anti-Double-Stranded DNA B Cells and Dendritic Cells J. Immunol., August 15, 2001; 167(4): 2370 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. BRAS, A. RUIZ-VELA, D. GARCIA-DOMINGO, and C. MARTINEZ-A Apoptosis as a Scaffold for Building up the B Cell Repertoire Ann. N.Y. Acad. Sci., December 1, 2000; 926(1): 13 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. R. Rifkin, E. A. Leadbetter, B. C. Beaudette, C. Kiani, M. Monestier, M. J. Shlomchik, and A. Marshak-Rothstein Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells J. Immunol., August 1, 2000; 165(3): 1626 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Tucker, T. J. Vyse, S. Rozzo, C. L. Roark, S. Izui, and B. L. Kotzin Genetic Control of Glycoprotein 70 Autoantigen Production and Its Influence on Immune Complex Levels and Nephritis in Murine Lupus J. Immunol., August 1, 2000; 165(3): 1665 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Majlessi and G. Bordenave Non-overlapping Fas- and BCL-2-regulated death pathways in IgG2ab-producing B cells Int. Immunol., July 1, 2000; 12(7): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Korner, E. Cretney, P. Wilhelm, J. M. Kelly, M. Rollinghoff, J. D. Sedgwick, and M. J. Smyth Tumor Necrosis Factor Sustains the Generalized Lymphoproliferative Disorder (gld) Phenotype J. Exp. Med., January 3, 2000; 191(1): 89 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang and M. J. Shlomchik Autoantigen-specific B Cell Activation in Fas-deficient Rheumatoid Factor Immunoglobulin Transgenic Mice J. Exp. Med., September 6, 1999; 190(5): 639 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Goulet, R. C. Griffiths, P. Ruiz, R. F. Spurney, D. S. Pisetsky, B. H. Koller, and T. M. Coffman Deficiency of 5-Lipoxygenase Abolishes Sex-Related Survival Differences in MRL-lpr/lpr Mice J. Immunol., July 1, 1999; 163(1): 359 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mohan, Y. Yu, L. Morel, P. Yang, and E. K. Wakeland Genetic Dissection of Sle Pathogenesis: Sle3 on Murine Chromosome 7 Impacts T Cell Activation, Differentiation, and Cell Death J. Immunol., June 1, 1999; 162(11): 6492 - 6502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Majlessi and G. Bordenave Evidence of Alternative or Concomitant Use of Perforin- and Fas-Dependent Pathways in a T Cell-Mediated Negative Regulation of Ig Production J. Immunol., April 15, 1999; 162(8): 4391 - 4398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M L Huggins, F-P Huang, D Xu, G Lindop, and D I Stott Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-{beta}1 gene therapy using attenuated Salmonella typhimurium as gene carrier Lupus, January 1, 1999; 8(1): 29 - 38. [Abstract] [PDF]
|
|
|
|
|
|
L. Gu, A. Weinreb, X.-P. Wang, D. J. Zack, J.-H. Qiao, R. Weisbart, and A. J. Lusis Genetic Determinants of Autoimmune Disease and Coronary Vasculitis in the MRL-lpr/lpr Mouse Model of Systemic Lupus Erythematosus J. Immunol., December 15, 1998; 161(12): 6999 - 7006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Putterman and B. Diamond Immunization with a Peptide Surrogate for Double-stranded DNA (dsDNA) Induces Autoantibody Production and Renal Immunoglobulin Deposition J. Exp. Med., July 1, 1998; 188(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Foote, A. Marshak-Rothstein, and T. L. Rothstein Tolerant B Lymphocytes Acquire Resistance to Fas-mediated Apoptosis after Treatment with Interleukin 4 but Not after Treatment with Specific Antigen Unless a Surface Immunoglobulin Threshold Is Exceeded J. Exp. Med., March 16, 1998; 187(6): 847 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Milich, M. K. Chen, J. L. Hughes, and J. E. Jones The Secreted Hepatitis B Precore Antigen Can Modulate the Immune Response to the Nucleocapsid: A Mechanism for Persistence J. Immunol., February 15, 1998; 160(4): 2013 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Mannick, X. Q. Miao, and J. S. Stamler Nitric Oxide Inhibits Fas-induced Apoptosis J. Biol. Chem., September 26, 1997; 272(39): 24125 - 24128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirose, K. Yan, M. Abe, Y. Jiang, Y. Hamano, H. Tsurui, and T. Shirai Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination PNAS, August 19, 1997; 94(17): 9291 - 9295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Drappa, A. K. Vaishnaw, K. E. Sullivan, J.-L. Chu, and K. B. Elkon Fas Gene Mutations in the Canale-Smith Syndrome, an Inherited Lymphoproliferative Disorder Associated with Autoimmunity N. Engl. J. Med., November 28, 1996; 335(22): 1643 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bazzoni and B. Beutler The Tumor Necrosis Factor Ligand and Receptor Families N. Engl. J. Med., June 27, 1996; 334(26): 1717 - 1725. [Full Text] [PDF]
|
|
|
|
 |
|
 S Nagata and P Golstein The Fas death factor Science, March 10, 1995; 267(5203): 1449 - 1456. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
